ROIVANT SCIENCES LTD. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ROIVANT SCIENCES LTD. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $199.82M.
- ROIVANT SCIENCES LTD. stock issued during period, value, new issues for the quarter ending 2022-12-31 was $94.73M, a 68.82% increase year-over-year.
- ROIVANT SCIENCES LTD. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $0.00.
- ROIVANT SCIENCES LTD. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $56.12M, a 180.58% increase year-over-year.
- ROIVANT SCIENCES LTD. stock issued during period, value, new issues for fiscal 2023 was $311.68M, a 445.21% increase from fiscal 2022.
- ROIVANT SCIENCES LTD. stock issued during period, value, new issues for fiscal 2022 was $57.17M, a 81.05% decline from fiscal 2021.
- ROIVANT SCIENCES LTD. stock issued during period, value, new issues for fiscal 2021 was $301.74M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-09-30 | $199.82M 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $311.68M 10-K · filed 2023-06-28 | |
| 2022-12-31 | $94.73M 10-Q · filed 2023-02-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $57.17M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $56.12M 10-Q · filed 2023-02-13 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $301.74M 10-K · filed 2022-06-28 | |
| 2020-12-31 | $20.00M 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |